Compare UBC Medical Indonesia Tbk. (LABS) vs Trimuda Nuansa Citra Tbk. (TNCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
UBC Medical Indonesia Tbk. vs Trimuda Nuansa Citra Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume), while Trimuda Nuansa Citra Tbk. trades at Rp180 (market cap 78B, 8.56M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 8.9× Trimuda Nuansa Citra Tbk.'s market cap, and Trimuda Nuansa Citra Tbk. is more actively traded (8.56M versus 635.5K). Which is the better fit depends on your goals.
| LABS | TNCA | |
|---|---|---|
Market Cap | 691.25B | 78B |
Volume | 635.5K | 8.56M |
Lot | 6.36K | 85.6K |
Turnover | 110.15M | 1.65B |
Average Price | 173.33 | 192.97 |
Value | 110.15M | 1.65B |
Indicative Equilibrium Price | 174 | 180 |
Indicative Equilibrium Volume | 50 | 589 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →About Trimuda Nuansa Citra Tbk.
PT Trimuda Nuansa Citra Tbk(the Company) was established in Indonesia in accordance with Deed of Establishment of Limited Liability Company Company No. 21 dated May 4, 1995 made before H. Asmawel Amin, S.H., Notary in Jakarta.
Read more on TNCA →
